Figure 5.
SVMAV reduced the pulmonary metastasis of melanoma. (A) Schematic of the vaccination scheme and tumor challenge. (B) Photographs of lung tissues excised on day 37; red arrows highlight metastatic foci. (C) Histogram showing the numbers of lung metastases in different groups. (D) Representative H&E staining and Ki-67 IHC staining results of lung sections from different groups. *P<0.05. Black scale bar represents 100 µm (magnification, ×100). IHC, immunohistochemistry; SVMAV, Self-assembling Vehicle-free Multi-component Antitumor nanoVaccine.